QA: Edesa Biotech Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001540159_2023_Edesa_Biotech_Inc.pdf

Logs

Graph

Absolute values for 0001540159, Edesa Biotech Inc

  xvar xval
0 AssetsCurrent 9,091,913
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 12,694
3 remainder_Assets 2,471,121
4 LiabilitiesCurrent 2,140,777
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 43,662
7 CostOfGoodsAndServicesSold -1,807
8 SellingGeneralAndAdministrativeExpense -469,738
9 ResearchAndDevelopmentExpense 1,003,934
10 remainder_Expenses 800
11 remainder_Revenues 31,620
12 remainder_NetIncome -9,457,295
13 remainder_ComprehensiveNetIncome -8,340
  yvar yval
0 Assets 11,575,728
1 Liabilities 2,184,439
2 Expenses 533,189
3 Revenues 31,620
4 StockholdersEquity 9,391,289
5 NetIncome -9,958,864
6 ComprehensiveNetIncome -9,963,034
7 BaseVar 11,895,306
8 EconomicCapitalRatiobeforeLimitedLiability 1.53
9 EconomicCapitalRatio 2.70

Edgar->Model Mapping

Feature Distribution

Change over Time